<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Le traitement antir&#xE9;troviral comme moyen de pr&#xE9;vention (TasP)</dc:title>
  <dc:title>VIH, h&#xE9;patites virales, sant&#xE9; sexuelle</dc:title>
  <dc:creator>/Larmarange, Joseph</dc:creator>
  <dc:publisher>EDP Sciences</dc:publisher>
  <dc:contributor>Katlama, C. (ed.)</dc:contributor>
  <dc:contributor>Ghosn, J. (ed.)</dc:contributor>
  <dc:contributor>Wandeler, G. (ed.)</dc:contributor>
  <dc:date>2020</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010082470</dc:identifier>
  <dc:identifier>fdi:010082470</dc:identifier>
  <dc:identifier>Larmarange Joseph, . Le traitement antir&#xE9;troviral comme moyen de pr&#xE9;vention (TasP). In : Katlama C. (ed.), Ghosn J. (ed.), Wandeler G. (ed.), . VIH, h&#xE9;patites virales, sant&#xE9; sexuelle EDP Sciences, 2020, 702-711</dc:identifier>
  <dc:language>FR</dc:language>
  <dc:coverage>EUROPE</dc:coverage>
  <dc:coverage>AMERIQUE DU NORD</dc:coverage>
  <dc:coverage>AFRIQUE SUBSAHARIENNE</dc:coverage>
  <dc:coverage>BOTSWANA</dc:coverage>
  <dc:coverage>KENYA</dc:coverage>
  <dc:coverage>OUGANDA</dc:coverage>
  <dc:coverage>ZAMBIE</dc:coverage>
  <dc:coverage>MALAWI</dc:coverage>
  <dc:coverage>AFRIQUE DU SUD</dc:coverage>
</oai_dc:dc>
